Opioid toxicity

Background

  • Obtain acetaminophin levels in all cases of combination opioid-acetaminophen overdoses
  • Respiratory depression is the cause of all mortality from opioid toxicity
  • When prescribing opioid pain relievers in the ED, remember to have a discussion of co-ingestion of other depressants (alcohol involved in 1/5 of opioid related deaths)[1]
  • Consider contributing to the DAWN database for public ED research benefit (Drug Abuse Warning Network)

Clinical Features

  1. Common
    1. Miosis
    2. N/V
    3. Respiratory depression
    4. Mental status depression
  2. Uncommon
    1. QT prolongation (methadone)
    2. Seizure (tramadol)
    3. Acute lung injury

Differential Diagnosis

Sedative/hypnotic toxicity

Treatment

  1. Airway protection and ventilatory management
    • BVM and naloxone administration may prevent need for intubation
  2. Naloxone (Narcan)
    • Alsmost immediate onset of action
    • Dosing
      • Bolus (May repeat q3min up to max dose 10mg
        • Apneic or near-apneic - 2mg IV
        • Opioid-naive with minimal respiratory depression - 0.4mg IV
        • Opioid-dependent with minimal respiratory depression - 0.05mg IV
        • Duration of action = 20-90min (may be less than that of the ingested opioid)
      • Infusion
        • Only give if the pt responded to the bolus and required repeat administration
        • Step 1: Determine the "wake-up dose" or bolus required to wake the pt
        • Step 2: Give 2/3 of the "wake-up dose" per hr; mix in 1L D5W
  3. GI decontamination

Disposition

  1. Heroin intoxication:
    1. Consider discharge 1-2hr after naloxone administration if all are true:
      1. Independent mobility
      2. O2 sat >92% (room air)
      3. RR >10bpm
      4. HR >50
      5. Normal temp
      6. GCS 15
  2. Non-heroin intoxication:
    1. Consider discharge after 4-6hr obs

See Also

External Links

Source

  1. Jones CM, Paulozzi LJ, Mack KA. Alcohol Involvement in Opioid Pain Reliever and Benzodiazepine Drug Abuse–Related Emergency Department Visits and Drug-Related Deaths — United States, 2010. CDC MMWR. October 10, 2014 / 63(40);881-885.